International Workshop on Chronic Lymphocytic Leukemia September 20th – 23rd, 2019 Edinburgh International Conference Centre, Edinburgh, UK Invectys…
8th International Conference on HLA-G July 8th – 9th 2019 Ministère de la Santé et des Solidarités, Paris, France Invectys will be attending the 8th International…
Invectys will be attending the International Cancer Immunotherapy Conference 2019 in Paris.…
Healthtech Investor Day June 24th – 25th, 2019 The Peninsula Paris, Paris, France Pierre Langlade-Demoyen, our CEO, will be representing Invectys…
ICVI International Symposium on Immunotherapy May 24th – 25th, 2019 The Royal Society, London, UK Invectys will be attending the Institute for…
Invectys secures €15 million equity financing to advance lead program INVAC-1 into groundbreaking phase II clinical trial in CLL Financing complements the…
After its Phase I success, Invectys raises €4.3 million to enter Phase II with both of its anti-cancer vaccines Paris, July 12th, 2017 – This round brings…
Presentation of the Invectys clinical trial results on cancer patients at the most important worldwide oncology meeting taking place this year in Chicago, USA Paris,…